Landec Corp reports results for the quarter ended in February - Earnings Summary

Lifecore Biomedical

05/04/2022 22:01

* Landec Corp  LNDC.OQ  reported a quarterly adjusted loss
of 8
cents​​ per share for the quarter ended in February. The mean
expectation of five analysts for the quarter was for breakeven
results per share.
    * Revenue fell 61.5% to $53.07 million from a year ago; 
analysts
expected $48.41 million. 
    * Landec Corp's reported EPS for the quarter was a loss
of 24
cents​.
    * The mean earnings estimate of analysts had fallen by
about 108.3% in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Landec Corp shares had risen by 0.3% this quarter and
gained 4.6% so far this year.
    * The company reported a quarterly loss of $7.11 million.
    * Wall Street's median 12-month price target for Landec Corp
is
$14.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated April 5 at 09:00 p.m.  ​All
figures in US dollars unless otherwise stated